The seminar will be simulcast on the Internet, drawing in participants from around the world.
Featured at the symposium:
• Patient-centered presentations• Update on IBS research and role of the intestinal microbiome• Q&A with Cedars-Sinai gastroenterologists fielding questions from attendees and webinar guests• Live breath-testing demonstration to show how SIBO is detected in patients
WHO: Prominent IBS clinician and pioneering researcher Mark Pimentel, MD, director of the Cedars-Sinai GI Motility Program, is leading the symposium that will feature IBS experts from Cedars-Sinai. Pimentel’s groundbreaking research has identified specific biomarkers for the disease, paving the way for the development of the first blood test for IBS. A decade ago, Pimentel first proposed that the overgrowth of bacteria in the gut was a contributing cause of the disease.
WHEN: Saturday, July 19, 2014, 8:30 a.m.-5 p.m. PDT
WHERE: Cedars-Sinai Medical Center, Harvey Morse Conference Center,8700 Beverly Blvd., Los Angeles, CA 90048 REGISTER: Preregistration for in-person or webinar attendance is encouraged. Visit https://www.regonline.com/2014GlobalIBS. Fees range from $125 to $175.
# # #